BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

237 related articles for article (PubMed ID: 19352111)

  • 21. [High molecular-weight Bence Jones protein deposits in the kidney of a patient with plasma cell dyscrasia].
    Kitabayashi A; Komatsuda A; Miura AB; Yamaguchi A; Takatsu H; Fujita K
    Rinsho Ketsueki; 2000 Apr; 41(4):341-6. PubMed ID: 10846466
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Mechanisms of renal damage in plasma cell dyscrasias: an overview.
    Merlini G; Pozzi C
    Contrib Nephrol; 2007; 153():66-86. PubMed ID: 17075224
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Hepatic and renal deposits of kappa light chains revealing a dysglobulinemia (author's transl)].
    Mignon F; Morel-Maroger L; Cerf M; Preud'homme JL; Richet G
    Nephrologie; 1980; 1(4):167-70. PubMed ID: 6795518
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Free light chains in plasma of patients with light chain amyloidosis and non-amyloid light chain deposition disease. High proportion and heterogeneity of disulfide-linked monoclonal free light chains as pathogenic features of amyloid disease.
    Kaplan B; Ramirez-Alvarado M; Sikkink L; Golderman S; Dispenzieri A; Livneh A; Gallo G
    Br J Haematol; 2009 Mar; 144(5):705-15. PubMed ID: 19076171
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Paraproteinemic renal diseases that involve the tubulo-interstitium.
    Herrera GA; Sanders PW
    Contrib Nephrol; 2007; 153():105-15. PubMed ID: 17075226
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Light-chain-restricted plasmacellular infiltrates in necrobiosis lipoidica -- a clue to an underlying monoclonal gammopathy.
    Cioc AM; Frambach GE; Magro CM
    J Cutan Pathol; 2005 Apr; 32(4):263-7. PubMed ID: 15769274
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Plasma cell-rich acute cellular rejection of a transplanted kidney associated with antibody to the red cell Kidd antigen.
    Hamilton MS; Singh V; Warady BA
    Pediatr Transplant; 2006 Dec; 10(8):974-7. PubMed ID: 17096770
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Monoclonal immunoglobulin deposition disease associated with membranous features.
    Komatsuda A; Masai R; Ohtani H; Togashi M; Maki N; Sawada K; Wakui H
    Nephrol Dial Transplant; 2008 Dec; 23(12):3888-94. PubMed ID: 18596130
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Guidelines for the analysis of Bence Jones protein.
    Graziani M; Merlini G; Petrini C; ;
    Clin Chem Lab Med; 2003 Mar; 41(3):338-46. PubMed ID: 12705344
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Long-term outcome of renal transplantation in light-chain deposition disease.
    Leung N; Lager DJ; Gertz MA; Wilson K; Kanakiriya S; Fervenza FC
    Am J Kidney Dis; 2004 Jan; 43(1):147-53. PubMed ID: 14712438
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Long-term follow-up after autologous stem cell transplantation for light- and heavy-chain deposition disease.
    Brioli A; Zamagni E; Pasquali S; Tosi P; Tacchetti P; Perrone G; Pantani L; Petrucci A; Zannetti BA; Baccarani M; Cavo M
    Bone Marrow Transplant; 2012 Sep; 47(9):1248-9. PubMed ID: 22231462
    [No Abstract]   [Full Text] [Related]  

  • 32. Multiple myeloma and immunosecretory disorders: an update.
    Shaheen SP; Talwalkar SS; Medeiros LJ
    Adv Anat Pathol; 2008 Jul; 15(4):196-210. PubMed ID: 18580096
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Protein chemistry determines light chain-mediated renal damage in patients with plasma cell dyscrasias: a molecular understanding of variable manifestations].
    Herrera GA
    Zhonghua Bing Li Xue Za Zhi; 2003 Dec; 32(6):497-9. PubMed ID: 15038346
    [No Abstract]   [Full Text] [Related]  

  • 34. Renal lesions in plasma cell dyscrasias: ultrastructural observations.
    Pirani CL; Silva F; D'Agati V; Chander P; Striker LM
    Am J Kidney Dis; 1987 Sep; 10(3):208-21. PubMed ID: 3115092
    [TBL] [Abstract][Full Text] [Related]  

  • 35. IgA lambda monoclonal gammopathy with Bence Jones proteinuria and intestinal plasmacytoma in a renal transplant recipient.
    Pascali E; Pezzoli A
    Quad Sclavo Diagn; 1987 Dec; 23(4):363-8. PubMed ID: 3149785
    [No Abstract]   [Full Text] [Related]  

  • 36. Free immunoglobulin light chains as a risk factor in renal and extrarenal complications.
    Cohen G; Hörl WH
    Semin Dial; 2009; 22(4):369-72. PubMed ID: 19708983
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Clinical value of the blood measurement of the free light chains of immunoglobulins].
    Bidet A; Marit G; Bérard AM
    Ann Biol Clin (Paris); 2008; 66(4):427-31. PubMed ID: 18725344
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Fibrillary glomerulopathy secondary to light chain deposition disease in a patient with monoclonal gammopathy.
    Sundaram S; Mainali R; Norfolk ER; Shaw JH; Zhang PL
    Ann Clin Lab Sci; 2007; 37(4):370-4. PubMed ID: 18000296
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Primary kidney allograft dysfunction due to myeloma-cast nephropathy: a case report.
    Perkowska-Ptasinska A; Glyda M; Paczkowski M; Durlik M
    Transplant Proc; 2007 Jun; 39(5):1683-4. PubMed ID: 17580219
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Cerebral immunoglobulin light chain amyloid angiopathy-related hemorrhages.
    Mawet J; Adam J; Errera MH; Oksenhendler E; Gray F; Massin P; Bousser MG; Vahedi K
    Rev Neurol (Paris); 2009; 165(6-7):583-7. PubMed ID: 19124139
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.